7 Questions for Correlia Biosystems Co-Founder Akwasi Apori

A ​CITRIS Foundry​ company, Correlia Biosystems represents ​the next generation of the life science industry. With their patented nanomaterial, they ​develop microscale tools to accelerate molecular interactions to measure proteins, thereby ​reducing the cost and time of drug development, clinical trials, and patient testing and monitoring​. Founded in 2013, the eight-employee company is headquartered in Berkeley and has raised $2.6 million in funding. They are already running a pilot service business and they plan to launch their first commercial instrument in 2021. Akwasi Apori received his PhD in bioengineering at UC Berkeley after earning a bachelor’s and master’s degree in aeronautics and astronautics at MIT. In 2013, Correlia Biosystems joined the CITRIS Foundry, the in-house incubator of the multicampus CITRIS and the Banatao Institute headquartered at UC Berkeley.

CITRIS Foundry event welcomes spring 2020 cohort

The new spring cohort of CITRIS Foundry teams was announced February 13 at a Foundry event featuring Rich Lyons, UC Berkeley’s first-ever Chief Innovation and Entrepreneurship Officer. The 32 teams cover deep tech fields from AI and engineering systems to materials science and biotechnology, tackling issues including health care, energy and the environment, transportation, and sustainable infrastructure.

CITRIS Foundry – Spring 2020 Cohort

In Spring 2020, the CITRIS Foundry welcomed 32 teams covering deep tech fields from AI and engineering systems to materials science and biotechnology, tackling issues […]